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Abstract The purpose of this study was evaluation of the
prevalence of co-infection with Borrelia species ,
A. phagocytophilum and Babesia spp. in patients with tick-
borne encephalitis (TBE). At total of 110 patients with TBE
were included in the study. Serological tests for tick-borne
encephalitis virus (TBEV), PCR for Borrelia species,
Anaplasma phagocytophilum and Babesia spp., blood smears
for A. phagocytophilum and Babesia spp. and BLAST analy-
sis for Babesia spp. were performed. Results showed a signif-
icant majority of patients co-infected with Borrelia species
(30/110; 27 %), much less with A. phagocytophilum (12/110;
10.9 %) and with Babesia spp. (1/110; 0.9 %). The BLAST
analysis of the 18S rDNA sequence obtained with the Babesia
spp. specific primers indicated that the patient was infected
with Babesia microti. Triple co-infections (TBEV-Borrelia
species- A. phagocytophilum) were observed in three (3/110;
2.7 %) patients. Conclusions were such that differential diag-
nosis in patients after the tick bite, presenting with acute
symptoms, should include not only TBE and Lyme disease,
but also other diseases transmitted by ticks. In patients with
low parasitemia in suspicion of Babesia spp. infection PCR
seems to be a more sensitive method than blood smear. Co-
infection with various tick-borne pathogens must be always
considered, especially in endemic regions.
Introduction
It is known that certain tick species are able to transmit more
than one pathogen, e.g. tick-borne encephalitis virus (TBEV),
Borrelia burgdorferi sensu lato (Borrelia species), Anaplasma
phagocytophilum (A. phagocytophilum), and Babesia species
(Babesia spp.), which may be a reason for co-infections [1].
Co-infections are becoming a serious epidemiological and
clinical problem, especially due to the fact that the methods
of treatment of infectious diseases caused by various tick-
borne pathogens differ from each other. Therefore, this fact
is more frequently considered in clinical research, especially
in the areas endemic for tick-borne diseases. We suppose that
positive results of PCR tests, especially in patients with non-
specific symptoms in an early phase of infection, when anti-
bodies cannot be detectedwith the help of traditional methods,
may be helpful in the diagnosis and introduction of treatment
of zoonoses such as Lyme disease (LD), tick-borne encepha-
litis (TBE), anaplasmosis or babesiosis.
Objective
The objective of our study was to evaluate the prevalence of
infection with Borrelia species, A. phagocytophilum and
Babesia spp. in patients with TBE hospitalized between July
2009 and October 2012 in The Department of Infectious
Diseases and Neuroinfections of Medical University of
Bialystok, Poland.
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A group of 110 patients with TBE (47 female and 63 male)
was included in the study. None of patients was vaccinated
against TBE and all of them had a history of tick bites.
Diagnosis was made on the basis of clinical manifestation,
cerebrospinal fluid (CSF) examination and the presence of
serum and CSF specific antibodies. Anti/TBEV antibodies
titer was measured with SERION ELISA classic TBE Virus
IgG/IgM (Institut Virion/Serion GmbH, Germany). Patients
presented symptoms as shown in Table 1. None of them was
immunocompromised. Laboratory tests and cerebrospinal
tests results, as well as levels of TBEV antibodies are also
presented in Table 1.
Serum was collected to search for anti/TBEV and
anti/Borrelia burgdorferi antibodies. Whole blood in EDTA
was used for PCR for Borrelia species, Babesia spp. and
A. phagocytophilum. Blood smears were performed to search
for Babesia spp. and A. phagocytophilum circulating stages.
Cerebrospinal fluid was collected to perform biochemical,
immunological and PCR examination.
A control group (CG) consisted of 20 healthy blood do-
nors, in whom PCR for Borrelia species, Babesia spp. and
A. phagocytophilum and blood smears were performed.
The study was approved by the Bioethical Commission of
the Medical University of Bialystok.
DNA isolation
DNA isolation was performed with the 200 μl of fresh or kept
in +4 °C whole blood according to QIAamp DNA Mini Kit
(Qiagen, Germany). DNA extracts in 100 μl volume were
received from doubled elution by the mini spin column.
PCR amplifications
For detection of particular tick-borne pathogens: Borrelia
species, Babesia spp., A. phagocytophilum specific conserva-
tive genes were used. Sequence for protozoan Babesia: F2 (5′
GAC ACA GGG AGG TAG TGA CAA G 3′) and R2 (5′-
biotin CTA AGA ATT TCA CCT CTG ACA GT 3′) ampli-
fying a fragment from V4 region of 18S rDNA gene [2] were
synthesized by Sigma-Aldrich (Germany) and performed with
Taq PCRCore Kit (Qiagen, Germany). In reaction for Babesia
spp., 5 μl of extracted DNAwere added to a reaction mixture
(total volume of 50 μl) containing 5 μl of buffer x 10 with
15 mM MgCl2 (Qiagen, Germany), 2 μl of 25 mM MgCl2,
1 μl 10 mM dNTPs, 1 μl 20 μM of each primer and 0.25 μl
(5U/μl) Taq DNA polymerase (Qiagen, Germany). The ex-
perimental constructed amplification programme included ini-
tial denaturation at 94 °C for 3 min, 40 cycles (denaturation at
94 °C for 40s, annealing at 58 °C for 60s, extension at 72 °C
for 60s) and final extention at 72 °C for 10 min [3–5].
Amplification of A. phagocytophilum genetic material was
performed with the diagnostic kit PCR Anaplasma (Blirt-
DNA Gdańsk, Poland) coding a fragment of 16S rDNA gene
encoding small ribosomal 16S RNA subunit. Analyses were
conducted in accordance with the manufacturers instruction,
in the period from 2009 to 2011 in single PCR and in 2012 in a
nested type of PCR. In conventional, single course PCR in
2011, 1 μl of the template DNA isolate was added to 43.7 μl
of the Master Mix with 5 μl of dNTPs and 0.3 μl of
Hypernova polymerase for a final reaction mix volume of
50 μl. Amplification was performed in the following PCR
program: initial denaturation at 94 °C for 5 min, 35 cycles
(denaturation at 94 °C for 30 s, annealing at 56 °C for 30 s,
extension at 72 °C for 3 s) and final extension at 72 °C for
2 min. Positive results were 227 bp long fragments of the 16S
rDNA gene. Nested PCR for A. phagocytophilum DNA de-
tection was performed in two amplifications. In the first, PCR-
OUT 2 μl of the template DNA isolates was added to 42 μl of
the Master Mix with 5 μl of dNTPs and 1 μl of Taq nova
polymerase for a final reaction mix volume of 50 μl. First
amplification was performed in the following PCR program:
Table 1 Laboratory and cerebrospinal tests results, levels of tick-borne
encephalitis virus (TBEV) antibodies and symptoms in TBE patients
Symptoms and laboratory tests results TBE patients, N=110
Headache 103 (93 %)
Vertigo 23 (21 %)
Nausea 40 (36 %)
Vomits 32 (30 %)
Fever 96 (87 %)
Muscle pain 20 (18 %)
Joint pain 20 (18 %)
Erythema migrans 0
Meningeal signs presence 90 (81 %)
Anti/TBEV IgM serum (mean) IU/ml 14 (cut off −0.45) 98 % of
patients were positive
Anti/TBEV IgG serum (mean) IU/ml 30 (cut off –0.27) 95 % of
patients were positive
Anti/TBEV IgM CSF (mean) IU/ml 4 (cut off −0.45) 80 % of
patients were positive
Anti/TBEV IgG CSF (mean) IU/ml 8.8 (cut off –0.27) 82 % of
patients were positive
CRP (mean ± SD) mg/dl 11.4±12.5
SD (mean ± SD) mm/h 27.6±15.7
WBC (mean ± SD) (tys) 9.1±3.4
RBC (mean ± SD) (mln) 4.4±0.5
PLT (mean ± SD) (×100 tys) 203.4±56.5
CSF cytosis (mean ± SD) cells/μl 111±154.6
CSF protein concentration
(mean ± SD) (mg/dl)
63.9±20.7
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initial denaturation at 95 °C for 2 min, 40 cycles (denaturation
at 94 °C for 30 s, annealing at 55 °C for 30 s, extension at
72 °C for 60 s) and final extension at 72 °C for 5 min. In a
second amplification, PCR-IN, despite DNA isolate to 42 μl
of the Master Mix with 5 μl of dNTPs and 1 μl of Taq nova,
2 μl of PCR product from first reaction was added. The PCR-
IN program follows as in PCR-OUT, but in 30 cycles. Pres-
ence of the 16S rDNA gene fragments: 932 bp long in PCR-
OUTand 546 bp long in PCR-IN attest toA. phagocytophilum
infection. Lack of 932 bp long fragments in PCR-OUT does
not exclude a positive result of test.
Borrelia species Molecular detection was performed by using
the Borrelia burgdorferi PCR kit (GeneProof, Czech Repub-
lic) for in vitro diagnostics. The kit is designed for profession-
al use in specialized clinical and research laboratories. The kit
is designed for the detection ofBorrelia burgdorferi sensu lato
sp. group on the principle of amplification of the specific
DNA sequence of a 276 bp fragment of flagellin encoding
gene by nested one tube PCR. The template DNA extract was
added to 36 μl of the MasterMix for a final reaction mix
volume of 40 μl. “Hot start” technology was used in the
detection kit, minimizing risk of non-specific reactions and
maximizing sensitivity of procedure. Eventual PCR inhibition
was controlled by internal standard in the reaction mix. Ad-
dition of uracil-DNA-glycosylase (UDG) eliminated possible
contamination during preparation of the reaction. Nested PCR
was performed in compatibility to GeneProof instruction with
our own modifications. The course of the amplification was
prepared according to the following reaction program: UDG
decontamination at 37 °C for 2 min, initial denaturation at
96 °C for 10 min, first amplification for 30 cycles (denatur-
ation at 96 °C for 20 s, annealing at 68 °C for 20 s, extension at
72 °C for 40 s), second amplification for 45 cycles (denatur-
ation at 96 °C for 20 s, annealing at at 54 °C for 20 s, extension
at 72 °C for 30 s) and final extension at 72 °C for 2 min.
All amplifications were conducted on SensoQuest
LabCycler (SensoQuest, Germany). Received PCR
products were separated by electrophoresis in 2 %
agarose gel (Sigma-Aldrich, Germany) stained with
ethidium bromide (5 μg/1 ml; Syngen, USA). Electro-
phoresis conditions for A. phagocytophilum and
Babesia spp. were 80 V by 60 min and for Borrelia
species 80 V by 80 min. The results obtained were
viewed under UV light and visualized by Gel Logic
System 100 camera (Kodak, Imaging System, Inc.,
USA) (Figs. 1, 2, 3).
The amplification product for Babesia spp. showed 94 %
homology to sequences received in Gen Bank NCBI in posi-
tions KC 581934.1, KC 470049.1, AY 789075.1 and AB
071177.1, which indicated Babesia microti presence.
For A. phagocytophilum the specificity and selectivity were
determined by bioinformatic method using the NCBI
database. Lack of specificity of tick DNA template kit was
confirmed experimentally. Results of analysis showed that the
system selectively detects only A. phagocytophilum DNA. In
addition, the integrated package does not show homology to
DNA templates of other prokaryotes or eukaryotes.
As positive controls we used DNA extracted from a
deer spleen infected with Babesia spp.; in Borrelia
species and in A. phagocytophilum cases a positive
control was included in the particular kits. In a negative
control redistilled water replaced DNA isolates. The size
of amplification products for fla gene of Borrelia
species was 276 base pairs (bp), for Babesia spp. 18S
rDNA approximately 420 bp and for A. phagocytophilum
16S rDNA 227 bp in the 2009–2011 period and 546 bp
in 2012.
Nucleotide sequencing of the Babesia 18 rDNA amplicon
Amplification products of the Babesia spp. 18S rDNA were
purified using the QiaAmp PCR purification kit (Qiagen).
Sequencing reactions of both strands were performed using
Big Dye Terminator cycle sequencing kit (Applied
Biosystems) with the F2 and R2 primers under the same
conditions as above. Cycle sequencing reactions were purified
using the ExTerminator Kit (A&A Biotechnology, Gdynia,
Poland) and sequenced with the ABI3500 automated
Fig. 1 Electrophoretical detection of amplification of Borrelia
burgdorferi sl PCR products on agarose gel. M 100–500 bp molecular
weight marker; K+ positive control; K- negative control; 420 bp-internal
standard; 276 bp positive B. burgdorferi sl fragments of fla gene; lines:
2,3,5 positive samples; lines: 1, 4, 6, 7, 8, 9 negative samples
Fig. 2 Electrophoretical detection of amplification of Anaplasma
phagocytophilum PCR products on agarose gel.M 100–500 bpmolecular
weight marker; K+ positive control; K-negative control; 227 bp positive
Anaplasma phagocytophilum fragments of 16S rDNA gene; lines: 3, 5
positive samples, lines: 1, 2, 4, 6, 7, 8, 9, 10 negative samples
Eur J Clin Microbiol Infect Dis (2014) 33:1835–1841 1837
sequencer (Applied Biosystems, Foster City, USA). The
obtained sequences were compared with sequences col-
lected in the NCBI database (http://www.ncbi.nlm.nih.
gov).
Immunoserology diagnostic
The detection of TBE virus infection was performed with
SERION ELISA classic TBE Virus IgG/IgM (Institut Virion/
Serion GmbH, Germany) diagnostic kit twice in patients with
meningitis or encephalitis, namely, at the time of admission to
the hospital and 2 weeks later. Anti/TBEV antibody level
dynamics were observed. A level of viral specific IgM and
IgG antibodies was marked according to manufacturer’s
recommendations.
Anti/B. burgdorferi IgM and IgG antibodies in enzyme-
linked immunosorbent assay (ELISA; Borrelia recombinant
IgG and IgM High Sensitivity, Biomedica, Austria) and intra-
thecal production of anti/B. burgdorferi antibodies (EcoLine
test, Virotech Classic Kits, Germany) in cases with suspicion
of neuroborreliosis were performed.
Blood smears
Obligatory, from full blood collected on EDTA, blood smears
stained with May-Grunwald and Giemsa (MGG) were per-
formed twice. Piroplasm forms in erythrocytes were searched
for Babesia spp. infection and morulae in neutrophiles for
A. phagocytophilum infection.
Statistical analysis
Statistical analysis to compare patients with only TBE infec-
tion and co-infections was performed using Statistica 10.
Groups were compared by Mann–Whitney and Pearson’s
chi-squared tests. P value <0.05 was considered statistically
significant.
Results
In our study, conducted in the northeastern part of Poland on a
group of 110 patients with TBE, a significant majority was co-
infected with Borrelia species (30/110; 27 %), much less with
A. phagocytophilum (12/110; 10.9 %) and with Babesia spp.
(1/110; 0.9 %). The BLAST analysis of the 18S rDNA se-
quence obtained with the Babesia spp. specific primers indi-
cated that the patient was infected with Babesia microti. One
patient was diagnosed as neuroborreliosis, based on
anti/B. burgdorferi IgM and IgG serum antibodies and intra-
thecal production of anti/B. burgdorferi antibodies in CSF.
Triple co-infections (TBEV-Borrelia species- A.
phagocytophilum) were observed in three (3/110; 2.7 %)
patients.
In blood smear we observed no piroplasm forms in eryth-
rocytes typical of Babesia spp. infection or morulae in
neutrophiles typical of A. phagocytophilum infection.
Analysis of patients infected only with TBEV and patients
co-infected with other pathogens showed no significant differ-
ence in the presented symptoms, which indicates overlapping
of symptoms in cases of TBEV infection. However, there were
significant differences in the laboratory parameter values such
as the erythrocyte sedimentation rate (ESR) (p=0.028) and
alanine aminotransferase activity (p=0.006) (Tables 2 and 3).
Discussion
In Poland, similarly to other European countries, tick-borne
diseases are an increasing epidemiological and clinical prob-
lem. Annual incidence of LD has also been increasing sys-
tematically. The number of registered cases in 2005 and 2009
was 4.406 (incidence 11.5/100.000 inhabitants) and 10,333
cases (incidence 27.1/100.000 inhabitants), respectively. Dur-
ing a period of 5 years a 2-fold increase in LD incidence has
been observed. The regions considered to be endemic are the
Podlaskie and Warminsko-Mazurskie regions (northeastern
Poland) with annual 5-fold higher incidence in comparison
to the whole country. In 2012, a total of 9.159 cases were
reported (incidence 24/100.000 inhabitants) [6].
TBE incidence has also been increasing for years. The
number of registered cases in 2005 and 2009 was 174 (inci-
dence 0.46/100.000 inhabitants) and 344 (incidence 0.9/
100.000 inhabitants), respectively. In 2012, 188 cases were
reported (incidence 0.49/100.000 inhabitants). Similarly to
LD most cases have been observed in the Podlaskie and
Warminsko-Mazurskie regions [6].
At the moment the exact number of cases suffering from
anaplasmosis and babesiosis is unknown. At the same time, it
is known that from 1956, only in Europe, more than 50 cases
of human babesiosis have been confirmed [7–9]. Human
Granulocytic Ehrlichiosis (HGE, anaplasmosis) has been
Fig. 3 Electrophoretical detection of amplification of Babesia species
PCR products on agarose gel. M 100–500 bp molecular weight marker;
K+ positive control; K- negative control; 420 bp positive Babesia species
fragments of 18S rDNA gene; line: 9 positive samples; lines: 1, 2, 3, 4, 5,
6, 7, 8, 10, 11 negative samples
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diagnosed from 1994 in the United States, from 1996 in
Europe and from 2001 in Poland [7]. Despite that, only a
few cases have been described. For example, due to the
research of Welc-Falęciak et al., in a group of 30 tick-
exposed people from southeastern Poland only one case of
Babesia spp. (1/30; 3.3 %) and one of A. phagocytophilum
(1/30; 3.3 %) infection were confirmed with PCR [8].
It is known that more than one pathogen may co-exist in
one vector. According to various European sources, co-
infection of I. ricinus ticks with different pathogens appears
to be quite common [5, 10–13]. In Poland, the prevalence of
co-infected I. ricinus ticks with at least two pathogens varies
from 0.12–8.30 % and depends on the area of tick sampling
[1, 14–16].
Human co-infection with various pathogens may be the
result of a single tick bite by the tick infected with more than
one pathogen or the result of multiple bites by ticks infected
with one pathogen. Both situations may result in a co-
infection, often difficult to diagnose and differentiate [17].
Meer-Scheerer et al. described a case of B. microti and
Borrelia species co-infection [18]. Krause et al. observed that
in 1156 serosurvey subjects, 97 (8.4 %) were seroreactive
Table 2 Comparison of symptoms between patients only with tick-borne encephalitis (TBE) and patients with co-infections
Symptoms TBEV (N=70) TBEV + B. burgdorferi sl TBEV +
A. phagocytophilum TBEV +
Babesia spp. (N=40)
p
n % n %
Headaches 66 94.3 % 37 92.5 % 0.71
Vertigo 12 17.2 % 11 27.5 % 0.19
Nausea 23 33 % 17 42.5 % 0.31
Vomiting 22 31.4 % 10 25 % 0.47
Muscle pain 11 15.7 % 11 27.5 % 0.13
Joint pain 11 15.7 % 9 22.5 % 0.37
Fever 62 88.6 % 32 80 % 0.21
Meningeal signs presence 53 75.7 % 24 60 % 0.08
Neck stiffness 44 63 % 29 72.5 % 0.3
TBEV tick-borne encephalitis virus
Table 3 Comparison of laboratory test results between patients only with tick-borne encephalitis (TBE) and patients with co-infections
Laboratory parameters TBEV (N=70) TBEV + B. burgdorferi sl TBEV +
A. phagocytophilum TBEV +
Babesia spp. (N=40)
p
Mean SD Median Mean SD Median
ESR (mm/h) 34 21 30 45 19 46 0.028
CRP (mg/l) 9.9 10.8 7.5 14.4 15.2 8.4 0.16
RBC (mln/μl) 4.45 0.54 4.4 4.48 0.44 4.6 0.47
Hemoglobin (g/dl) 13.5 1.45 13.5 13.6 1.1 13.7 0.75
Hematocrit (%) 40.1 8.3 39.9 39.4 3.4 39.5 0.9
WBC (tys/μl) 9.03 3.2 9.02 9.13 4 9.3 0.98
PLT (tys/μl) 208 59 208 194 51 194 0.3
ALT (U/l) 34 37 22 21 25 13 0.006
AST (U/l) 28 23 21 20 8 17 0.14
LDH (U/l) 315 514 199 236 72 238 0.28
Creatinine (mg/dl) 0.76 0.15 0.74 0.77 0.17 0.78 0.62
Glucose (mg/dl) 99 16 99 103 31 95 0.71
Fibrynogen (mg/dl) 464 196 415 455 144 474 0.88
Bilirubin (mg/dl) 1.25 1.6 0.62 0.67 0.27 0.57 0.92
TBEV tick-borne encephalitis virus
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against LD spirochete antigen, of whom 14 (14 %) also were
seroreactive against babesial antigen [19]. Varis et al. de-
scribed patients simultaneously infected with TBEV and
B. burgdorferi spirochete as a result of a single tick bite
[20]. Cimperman et al. also identified patients who had ELISA
serum IgM and IgG antibodies of TBEV and a positive PCR
result for TBEV in cerebrospinal fluid as well as Borrelia
species i so la ted from cerebrospinal f lu id [21] .
Hermanowska-Szpakowicz et al. observed patients with LD
(8/96; 8.3 %) and patients with TBEV (4/96; 4.1 %)
coinfected only with A. phagocytophilum, but not with Babe-
sia microti [7].
In our study conducted in northeastern Poland we observed
a rate of co-infections of 2.7 %: B. burgdorferi/
A. phagocytophilum/TBEV. However, we observed a quite
high rate of co-infection with TBEV and Borrelia species
(27 % of patients with TBEV were positive for Borrelia
species), which was not observed in other studies. It may be
explained by pre-selections of patients, who were admitted to
hospital due to suspected meningitis. We also noticed a patient
with Babesia microti infection, which was asymptomatic or
with mild course. This observation may suggest significantly
higher importance of Babesia infection than it has been con-
sidered previously.
Various methods may be used to diagnose infections
caused by tick-borne agents. Among these are serological
examinations (TBE, LD, babesiosis, anaplasmosis), PCR
(LD, TBE, babesiosis, anaplasmosis) and blood smear (babe-
siosis, anaplasmosis) [22]. Each of these methods might be
used separately and it is not necessary to have positive results
of all of them simultaneously. The ideal situation would be to
obtain the same results from all available methods; however,
none of them has 100 % specificity and sensitivity. Blood
smear, which in some cases may be negative, is the best
example of problems in the diagnostic process. In general,
the analysis of blood smears is a fairly subjective process. The
need to discriminate the subtleties of babesial/anaplasmal
morphology and possible low parasitemias may result in
inaccurate diagnoses, which might require further analysis.
In cases of anaplasmosis suspicion 25–75 % of patients
have morulae in peripheral blood smear examinations, with
the highest sensitivity during the first week of infection [23].
Only one-third of patients with babesiosis have piroplasm
forms in erythrocytes in microscopic study [21]. Additionally,
Aktas et al. observed in sheep blood samples that only in four
out of 98 piroplasms B. ovis forms were present in thin blood
smears, whereas in PCR 21 samples were positive [24]. If
there is a strong suspicion of anaplasmosis or babesiosis and
parasitemia is low, detection of parasites may by difficult on a
thin blood smear, and molecular techniques are recommended
[22].
From the clinical point of view the influence of co-
infections on the course of disease and treatment
administration is the most important issue. Logina et al. ana-
lyzed 51 patients with double infection—TBEVand Borrelia
species—and concluded that the clinical occurrence of both
LD and TBE varies after exposure to tick bite, and the neuro-
logical manifestations of each disorder differ significantly,
with appreciable overlap [25]. However, their study provided
no proof that co-infection manifested with extraordinary
symptoms due to unexpected interaction between these two
pathogens. Nevertheless, they suggest that all the patients
from endemic areas presenting with acute neurological symp-
toms after the tick bite should be investigated for both LD and
TBE and simultaneous treatment of both conditions should be
introduced as quickly as possible.
In another study of 687 patients with TBE 2 % were
diagnosed with neuroborreliosis. They more frequently had
pleocytosis of over 300 cells/mm³ and statistically higher
concentration of protein (88.2 mg/dl vs 67.4 mg/dl). In the
group without neuroborreliosis, symptoms like headaches,
vertigo, nausea and vomiting were more frequent than neuro-
logical symptoms in comparison to the group with
neuroborreliosis [26].
On the other hand, Alekseev et al. suggested that Borrelia
species might suppress viral replication in ticks and in TBE-
susceptible individuals, hence it is still a matter of controversy
[27]. In our study no differences in clinical picture between
patients with only TBE infection and co-infection with other
tick-borne pathogens were stated.
Grab et al. suggested that A. phagocytophilum co-infection
contributes to the severity, dissemination and possible sequelae
of LD. They showed that co-infection enhanced reductions in
transendothelial electrical resistance and enhanced or synergisti-
cally increased production of metalloproteinases, cytokines and
chemokines, which are known to affect vascular permeability
and inflammatory responses [28].
Co-infection with Babesia and Borrelia species may influ-
ence the clinical course, especially in non-immunocompetent
patients, and might be difficult to diagnose due to the fact that
both diseases cause nonspecific symptoms, such as fever, fa-
tigue, and flu-like illness. Patients with an inadequate response to
appropriate therapy for proven or suspected LD following a tick
bite should be examined for infections with other tick-borne
agents, including Babesia species [28]. It is also worth remem-
bering during travel to endemic areas for tick borne diseases, as
babesiosis is starting to appear as a travel-related disease [29].
We assume that administration of antibiotic therapy in
cases suspected of co-infection should be introduced as soon
as possible and should be verified after the advanced labora-
tory test results, such as molecular biology methods (e.g.
PCR). We also should be aware that number of pathogens
transmitted on humans by ticks is constantly increasing (e.g.
Fransicella tularensis, Bartonella spp., spotted fever rickett-
siae group and many others) and further studies are necessary
[30].
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Conclusions
1. Nonspecific symptoms after tick bite may results from
presence of other than TBEV pathogens, not diagnosed
routinely.
2. In patients with low parasitemia in suspicion ofBabesia spp.
PCR seems to be amore sensitivemethod than blood smear.
3. Co-infection with various tick-borne pathogens must al-
ways be considered, especially in regions endemic for
these diseases.
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